CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2016	Aug. 02, 2015
Cash flows from operating activities:
Net income (loss)	$ 32,026	$ (588)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	32,107	38,038
Deferred financing cost amortization	1,431	1,006
Share-based compensation expense	7,711	7,702
Gain from bargain purchase	(1,864)	0
Gain on sale of assets and asset recovery	(1,704)	(15)
Provision for (recovery of) doubtful accounts	1,515	(645)
Provision for deferred income taxes	1,573	5,625
Excess tax benefits from share-based compensation arrangements	(867)	(706)
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	(10,102)	13,254
Inventories	(25,309)	(1,910)
Income taxes receivable	0	(2,634)
Prepaid expenses and other	1,150	1,071
Accounts payable	499	493
Accrued expenses	2,550	(22,106)
Other, net	(117)	6
Net cash provided by operating activities	40,599	38,591
Cash flows from investing activities:
Acquisitions, net of cash acquired	(4,343)	(247,123)
Capital expenditures	(15,140)	(15,330)
Proceeds from sale of property, plant and equipment	5,479	28
Net cash used in investing activities	(14,004)	(262,425)
Cash flows from financing activities:
Deposit of restricted cash	(44)	0
Proceeds from stock options exercised	12,055	354
Issuance of debt	0	250,000
Payments on term loan	(30,000)	(31,240)
Payments on note payable	(974)	(1,103)
Payment of financing costs	0	(9,218)
Excess tax benefits from share-based compensation arrangements	867	706
Purchases of treasury stock	(57,401)	(3,273)
Net cash (used in) provided by financing activities	(75,497)	206,226
Effect of exchange rate changes on cash and cash equivalents	(50)	(766)
Net decrease in cash and cash equivalents	(48,952)	(18,374)
Cash and cash equivalents at beginning of period	99,662	66,651
Cash and cash equivalents at end of period	$ 50,710	$ 48,277